| scholarly article | Q13442814 |
| P50 | author | Erik T Dustrude | Q89207878 |
| Matthew S Ripsch | Q115615314 | ||
| Rajesh Khanna | Q48357681 | ||
| P2093 | author name string | Fletcher A White | |
| Yuying Wang | |||
| Harold Kohn | |||
| Ki Duk Park | |||
| Xiao-Fang Yang | |||
| P2860 | cites work | The dual effect of membrane potential on sodium conductance in the giant axon of Loligo | Q22337073 |
| Synthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivatives | Q28278541 | ||
| International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels | Q28289125 | ||
| Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors | Q28572100 | ||
| An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels | Q28579315 | ||
| Synthesis and anticonvulsant activities of (R)-N-(4'-substituted)benzyl 2-acetamido-3-methoxypropionamides | Q33640451 | ||
| Merging the structural motifs of functionalized amino acids and alpha-aminoamides: compounds with significant anticonvulsant activities | Q33840785 | ||
| An animal model of neuropathic pain employing injury to the sciatic nerve branches | Q33897493 | ||
| Substituted N-(biphenyl-4'-yl)methyl (R)-2-acetamido-3-methoxypropionamides: potent anticonvulsants that affect frequency (use) dependence and slow inactivation of sodium channels | Q33951922 | ||
| Lacosamide | Q82771848 | ||
| The action potential in mammalian central neurons | Q34004305 | ||
| In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation | Q34055749 | ||
| The formalin test: scoring properties of the first and second phases of the pain response in rats. | Q34058687 | ||
| Resurgence of sodium channel research | Q34142210 | ||
| Synthesis and Anticonvulsant Activity of a New Class of 2-[(Arylalkyl)amino]alkanamide Derivatives | Q34458402 | ||
| Slow inactivation in voltage-gated sodium channels: molecular substrates and contributions to channelopathies | Q34562464 | ||
| Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy | Q34618958 | ||
| The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. | Q34701722 | ||
| Development and characterization of novel derivatives of the antiepileptic drug lacosamide that exhibit far greater enhancement in slow inactivation of voltage-gated sodium channels. | Q34865999 | ||
| Merging Structural Motifs of Functionalized Amino Acids and α-Aminoamides Results in Novel Anticonvulsant Compounds with Significant Effects on Slow and Fast Inactivation of Voltage-gated Sodium Channels and in the Treatment of Neuropathic Pain | Q35099293 | ||
| The formalin test: an evaluation of the method | Q35555523 | ||
| Voltage gated ion channels: targets for anticonvulsant drugs. | Q36002928 | ||
| The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain | Q36369795 | ||
| Identification of the benzyloxyphenyl pharmacophore: a structural unit that promotes sodium channel slow inactivation | Q36479712 | ||
| Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide | Q36644488 | ||
| (Biphenyl-4-yl)methylammonium chlorides: potent anticonvulsants that modulate Na+ currents | Q37347379 | ||
| The Na(V)1.7 sodium channel: from molecule to man. | Q38066723 | ||
| Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy | Q39222620 | ||
| Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity. | Q39314185 | ||
| Laboratory evaluation of antiepileptic drugs. Review of laboratory methods | Q39982626 | ||
| Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine | Q39996628 | ||
| Voltage-dependent ion channels in CAD cells: A catecholaminergic neuronal line that exhibits inducible differentiation | Q40838391 | ||
| Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease | Q43620394 | ||
| The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats | Q43674677 | ||
| Ranolazine reduces neuronal excitability by interacting with inactivated states of brain sodium channels | Q43683642 | ||
| The anti-nociceptive agent ralfinamide inhibits tetrodotoxin-resistant and tetrodotoxin-sensitive Na+ currents in dorsal root ganglion neurons | Q46373509 | ||
| Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain | Q46537390 | ||
| Standardization of the rat paw formalin test for the evaluation of analgesics | Q46781531 | ||
| Subthreshold sodium currents and pacemaking of subthalamic neurons: modulation by slow inactivation | Q48259982 | ||
| Biochemical and electrophysiological studies on the mechanism of action of PNU-151774E, a novel antiepileptic compound | Q48278287 | ||
| Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2. | Q48357626 | ||
| Preclinical evaluation of PNU-151774E as a novel anticonvulsant | Q48473326 | ||
| Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons | Q54022626 | ||
| Slow inactivation of the sodium conductance in squid giant axons. Pronase resistance | Q54579818 | ||
| Antiepileptic Drug Development Program | Q70373416 | ||
| Selective and potent monoamine oxidase type B inhibitors: 2-substituted 5-aryltetrazole derivatives | Q71566488 | ||
| Reinvestigation of the mixed carbonic anhydride method of peptide synthesis | Q72353919 | ||
| A note on a simple apparatus for detecting neurological deficit in rats and mice | Q74784538 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sodium channel activity | Q14905710 |
| P304 | page(s) | 316-330 | |
| P577 | publication date | 2014-12-09 | |
| P1433 | published in | ACS Chemical Neuroscience | Q2819059 |
| P1476 | title | Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lac | |
| P478 | volume | 6 |
| Q35706539 | Chimeric derivatives of functionalized amino acids and α-aminoamides: compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels. |
| Q26740905 | Emerging approaches in Parkinson's disease - adjunctive role of safinamide |
| Q50934270 | Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States |
| Q28074736 | Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs |
Search more.